In Case You Missed It! April 2024
This month’s newsletter highlights a selection of recently published peer-reviewed articles that piqued our interest, grouped by their most relative modality:
Home Hemodialysis (HHD)Peritoneal Dialysis (PD)
We hope you find these recent findings useful and of value in your day-to-day practice.
Home Hemodialysis Recent Findings
Patient Training and Patient Safety in Home Hemodialysis
The authors review the epidemiologic data characterizing the safety of home hemodialysis (HHD) as compared with conventional in-center hemodialysis and how patient training affects safety, while emphasizing the surprising lack of literature surrounding these topics.
Learn More
In Case You Missed It! March 2024
This newsletter highlights a selection of recently published peer-reviewed articles that piqued our interest, grouped by their most relative modality.
We hope you find these recent findings useful and of value in your day-to-day practice.
Home Hemodialysis (HHD) Recent Findings
Patient Survival with Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis
Patient survival, technique survival, hospitalization, and clinical, laboratory, and medication changes were retrospectively analyzed in 349 HHD patients treated with longer session duration, most on nocturnal, were compared to 1,047 concurrent, propensity-score matched in-center hemodialysis patients, using 47 variables with a long-term follow-up.
Learn More
In Case You Missed It! February 2024
This newsletter highlights a selection of recently published peer-reviewed articles that piqued our interest, grouped by their most relative modality.
We hope you find these recent findings useful and of value in your day-to-day practice.
Home Hemodialysis Recent Findings
Therapeutic vancomycin and daptomycin levels were analyzed in 5,000 simulated home hemodialysis (HHD) patients. Initial vancomycin and daptomycin doses were defined for 10 common HHD treatment regimens based on HHD treatment duration, days per week, and dialysate volume.
Learn More